View Older Stories

May 22, 2026 09:25AM China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck

May 7, 2026 09:01AM Novartis breaks ground on Texas radioligand therapy manufacturing site

May 1, 2026 02:02PM Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G

Apr 30, 2026 07:04AM Novartis announces new API manufacturing facility in North Carolina

Apr 30, 2026 07:01AM Novartis completes seventh US facility plan with North Carolina site

Apr 24, 2026 06:31AM Novartis wins positive EU opinion for SMA gene therapy Itvisma

Apr 9, 2026 03:55AM Novartis expands health programs to reach underserved communities globally

Mar 30, 2026 04:18AM Novartis reports positive two-year results for Fabhalta in kidney disease

Mar 27, 2026 04:03AM Novartis to acquire biotech Excellergy for up to $2 billion

Mar 23, 2026 04:52AM Novartis to present immunology data at dermatology meeting

Mar 20, 2026 08:21AM Novartis to acquire breast cancer drug developer for up to $3 billion

Mar 16, 2026 12:54PM Novartis taps debt markets to fund $12 billion Avidity acquisition

Mar 13, 2026 01:37PM Novartis gets FDA approval for Cosentyx in pediatric hidradenitis suppurativa

Mar 11, 2026 07:34AM Argus Upgrades Novartis (NVS) to Buy

Mar 11, 2026 04:37AM Increasing unusual call option volume: NVS BRBR BNO OMC QGEN SCO CGNX WEAT ZVRA

Mar 6, 2026 08:35AM Novartis shareholders approve 5.7% dividend increase at annual meeting

Feb 27, 2026 06:44AM Novartis receives positive European opinion for CSU treatment remibrutinib

Feb 18, 2026 06:19AM Novartis reports positive results for remibrutinib in chronic urticaria

Feb 17, 2026 09:37AM Novartis (NVS) PT Raised to $180 at TD Cowen

Jan 20, 2026 07:34AM Novartis CEO says company likely shielded from U.S. tariffs

Jan 16, 2026 12:01PM FDA grants Breakthrough Therapy status to Novartis ianalumab for Sjögren's

Jan 13, 2026 03:07PM Novartis licenses peptide asset from PepLib for radioligand therapy

Jan 6, 2026 01:37PM Barclays Upgrades Novartis (NVS) to Equalweight

Dec 31, 2025 06:01AM Drugmakers Raise Us Prices On 350 Medicines Despite Pressure From Trump - Reuters

Dec 19, 2025 02:32PM Novartis reaches agreement with US government on drug pricing measures

Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 17, 2025 09:00AM Novartis selects Salesforce Agentforce for global customer engagement

Dec 12, 2025 07:03AM Novartis breaks ground on North Carolina manufacturing hub

Dec 9, 2025 07:33AM Novartis reports positive Phase III results for ITP treatment combo

Dec 9, 2025 07:16AM Novartis reports long-term breast cancer treatment data at medical meeting

Dec 3, 2025 04:13AM Morgan Stanley Upgrades Novartis (NOVN:SW) (NVS) to Overweight

Dec 1, 2025 06:53AM UK and US poised to agree zero-tariffs deal on pharmaceuticals - The Times

Nov 25, 2025 03:37AM BofA Securities Upgrades Novartis (NOVN:SW) (NVS) to Buy

Nov 24, 2025 09:05AM TD Cowen on Novartis (NVS): 'Meet Management Meeting Showcases Growth Drivers And Pipeline'

Nov 19, 2025 12:36PM Novartis plans $23 billion US manufacturing expansion creating 700 North Carolina jobs

Nov 17, 2025 08:30AM The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet

Nov 12, 2025 05:01PM Novartis malaria drug meets primary endpoint in phase III trial

Nov 10, 2025 09:31AM Novartis opens radioligand therapy manufacturing facility in California

Nov 10, 2025 08:36AM TD Cowen on Novartis (NVS): 'Meetings With Management Highlight Multiple Drivers Of Business Momentum'

Nov 10, 2025 04:51AM TD Cowen Reiterates Hold Rating on Novartis (NOVN:SW) (NVS)

Oct 29, 2025 11:42AM Novartis (NVS) PT Raised to $126 at CFRA

Oct 29, 2025 10:31AM Novartis presents positive ianalumab data for Sjogren's disease

Oct 28, 2025 09:58AM Novartis completes acquisition of Tourmaline Bio

Oct 28, 2025 06:01AM Deutsche Bank Reiterates Buy Rating on Novartis (NOVN:SW) (NVS)

Oct 28, 2025 02:41AM Novartis (NVS) Misses Q3 EPS by 2c; offers outlook

Oct 27, 2025 04:00PM Novartis Q3 preview: BofA sees strong product momentum, potential EBIT Upgrade

Oct 27, 2025 06:20AM H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition

Oct 27, 2025 12:28AM Novartis to acquire Avidity Biosciences for $12 billion or $72 per share cash

View Older Stories